BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 11, 2021
View Archived Issues
Second interim analysis data from phase IIa study of vilobelimab in pyoderma gangrenosum
Read More
Resveratrol-triggered switches maximize cancer immunotherapy, reduce toxicity
Read More
Final topline data presented from DeCidE1 study of MVP-S in ovarian cancer
Read More
New PSMB8 inhibitors divulged by Shouyao Holdings
Read More
Jiangsu Chia Tai Tianqing Pharmaceutical Group patents BCR-ABL inhibitors
Read More
New MAP4K1 inhibitors identified at Blueprint Medicines
Read More
Mindset presents preclinical data for next-generation psychedelic drug families
Read More
Beta Pharma synthesizes new FGFR inhibitors
Read More
aTyr expands its research collaboration with Ohio State University
Read More
Positive interim data presented from phase I study of FTX-6058
Read More
Anti-PRNP monoclonal antibody decreases tau pathology in mouse Alzheimer's disease model
Read More
Kaleido and COPD Foundation collaborate to advance development of KB-109
Read More
Skye completes IND-enabling genotoxicity studies for THCVHS
Read More
Rezolute initiates phase Ib study of RZ-402 for DME
Read More
Goldfinch Bio initiates dosing in extension study of GFB-887 for patients with FSGS
Read More
Recombinant human NAGLU coexpressing S1S3 phosphotransferase developed for Sanfilippo B syndrome
Read More
China's NMPA approves IND for phase I/II study of BBM-H901
Read More
Positive topline data from phase Ia/Ib trial of CB-4211
Read More
InnoCare receives NMPA clearance for phase II study of orelabrutinib in ITP
Read More
CRN-04894 shows pharmacologic proof of concept in phase I study
Read More
